Summary report of the SF e-meeting, 8 June, 2011
This document is the summary report of the Stakeholder Forum e-meeting, 8 June 2011. It presents key discussion and actions points decided at this meeting. Agenda 1. Brief summary of discussions during EUnetHTA JA Plenary Assembly 2. Business Model, next steps 3. Update on pilots in WP activities 4. EUnetHTA JA 2 proposal – update […]
List of commentators for the WP5 JA1 Pilot Pazopanib Report
The list with commentators provides the contact information of all the organisations that properly submitted contributions. The list with commentators provides the contact information of all the organisations that properly submitted contributions. List of commentators for the WP5 JA1 Pilot Pazopanib Report
List of comments for the WP5 JA1 Pilot Pazopanib Report
The list of comments for the WP5 JA1 Pilot Pazopanib Report. The list provides the contact information of all the organisations that properly submitted their contributions. The list of comments for the WP5 JA1 Pilot Pazopanib Report. The list provides the contact information of all the organisations that properly submitted their contributions. This document is […]
WP5 JA1 Pilot Pazopanib Report+Appendix
The final version of the WP5 JA1 pilot assessment using the draft model for Rapid Relative Effectiveness Assessment of Pharmaceuticals and guidelines. The joint assessment involved the participation of 22 HTA organisations as authors on different domains or as reviewers. Find the full list on page 16 in side the report. The final version of the WP5 […]
Summary report of the f-t-f SF Meeting in Venice, 3 September, 2012
This document is the summary report of the f-t-f Stakeholder Forum Meeting in Venice, 3 September 2012. It presents key discussion and actions points decided at this meeting. Agenda 1. Opening 2. EUnetHTA Joint Action 1 (2010-2012) a) Update on the developments b) Experience gained in JA1 regarding stakeholder involvement c) Presenting EUnetHTA JA WP3, […]
Summary report of the SF e-meeting, 12 November, 2012
This document is the summary report of the f-t-f Stakeholder Forum Meeting, 12 November 2012. It presents key discussion and actions points decided at this meeting. Agenda A. General information and updates 1) SF meeting September 3, 2012, Venice 2) EUnetHTA Executive Committee meeting, Oct 3-4, Diemen 3) Joint Action 2 a. JA2 SF open […]
Summary report of the f-t-f SF meeting in Brussels, 5 February, 2013
This document is the summary report of the f-t-f Stakeholder Forum Meeting in Brussels, 5 February 2013. It presents key discussion and actions points decided at this meeting. Agenda Opening, presentation of participants Introduction to EUnetHTA Presentation, Q&A EUnetHTA JA2 3-year Work Plan Presentation of WP 1, 4, 5, 7, 8 work plans Presentation of […]
Summary report of the SF e-meeting, 9 April, 2013
This document is the summary report of the Stakeholder Forum e-meeting, 9 April 2013. It presents key discussion and actions points decided at this meeting. Agenda A. General information and updates: EUnetHTA Plenary Assembly meeting 21-22 March, 2013, Zagreb Joint Action 2 a. Discussion of implementation of Co-Chair function in the Stakeholder Forum b. Update […]
Summary report of the SF e-meeting, 4 June, 2013
This document is the summary report of the Stakeholder Forum e-meeting, 4 June 2013. It presents key discussion and actions points decided at this meeting. Agenda A. General information and updates: 1. Overview of action points (last e-meeting) and their status 2. JA2 WP updates 3. EUnetHTA Conference Rome 2014 (October) – theme, organisation, etc. 4. JA2 […]
WP5 JA1 Pilot Pazopanib Report+Appendix
WP5 JA1 Pilot Pazopanib Report+Appendix The final version of the WP5 JA1 pilot assessment using the draft model for Rapid Relative Effectiveness Assessment of Pharmaceuticals and guidelines. The joint assessment involved the participation of 22 HTA organisations as authors on different domains or as reviewers. Find the full list on page 16 in side the report. The […]
